FIELD: biotechnology.
SUBSTANCE: disclosed are a medium for accelerated release of an active substance from prolonged-action drugs for parenteral use, consisting of a peptide or protein, with a given amount of initial components and a method for preparing the medium.
EFFECT: inventions provide a wider range of effective agents when conducting an accelerated release of an active substance from prolonged-release medicinal preparations for parenteral use, consisting of a peptide or protein enclosed in microspheres of a biodegradable copolymer of DL-lactic and glycolic acid.
3 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION IN THE FORM OF MICROSPHERES FOR PROLONGED AND CONTROLLED RELEASE OF PEPTIDE MEDICINAL SUBSTANCE | 1992 |
|
RU2103994C1 |
| SOLID MEDICINAL FORM WITH PROLONGED EFFECT FOR PARENTERAL ADMINISTRATION AND METHOD FOR ITS PREPARING | 1997 |
|
RU2207845C2 |
| METHOD FOR MANUFACTURE OF MICROSPHERES CONTAINING MEDICINAL SUBSTANCES AS BIOLOGICALLY ACTIVE SUBSTANCE, ENCLOSED IN POLYMER MATRIX, USING MICROSPHERES PRODUCTION BY DOUBLE EMULSION METHOD | 2016 |
|
RU2635472C1 |
| PROLONGED ACTION THERAPEUTIC AGENT BASED ON ANASTROZOLE | 2017 |
|
RU2659689C1 |
| PROLONGED-RELEASE ANTITUMOUR THERAPEUTIC AGENT BASED ON ANASTROZOLE, ANTITUMOUR PREPARATION, OESTROGEN SYNTHESIS INHIBITOR | 2013 |
|
RU2548722C1 |
| PREPARATION OF POLYLACTIDE-POLYGLYCOLIDE MICROPARTICLES CHARACTERISED BY SIGMOIDAL RELEASE PROFILE | 2014 |
|
RU2658004C2 |
| PROLONGED RELEASE PHARMACEUTICAL COMPOSITION | 2016 |
|
RU2704813C2 |
| PHARMACEUTICAL COMPOSITION WITH PROLONGED RELEASE OF DODECAPEPTIDE INGRAMON | 2022 |
|
RU2793124C1 |
| COMPOSITION OF PROLONGED ACTION AND METHOD OF OBTAINING SAID COMPOSITION | 2006 |
|
RU2434644C2 |
| COMPOSITION OF PROLONGED EFFECT AND METHOD FOR PREPARING THIS COMPOSITION | 2002 |
|
RU2297240C2 |
